DK1934388T3 - Fremgangsmåde til lægemiddeludvikling - Google Patents

Fremgangsmåde til lægemiddeludvikling

Info

Publication number
DK1934388T3
DK1934388T3 DK06790302.1T DK06790302T DK1934388T3 DK 1934388 T3 DK1934388 T3 DK 1934388T3 DK 06790302 T DK06790302 T DK 06790302T DK 1934388 T3 DK1934388 T3 DK 1934388T3
Authority
DK
Denmark
Prior art keywords
drug development
drug
development
Prior art date
Application number
DK06790302.1T
Other languages
English (en)
Inventor
Gerald B Tometzki
Wim Meutermans
Johannes Zuegg
Original Assignee
Alchemia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005905465A external-priority patent/AU2005905465A0/en
Application filed by Alchemia Ltd filed Critical Alchemia Ltd
Application granted granted Critical
Publication of DK1934388T3 publication Critical patent/DK1934388T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02Monosaccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK06790302.1T 2005-10-04 2006-10-03 Fremgangsmåde til lægemiddeludvikling DK1934388T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005905465A AU2005905465A0 (en) 2005-10-04 Method of Drug Design
PCT/AU2006/001431 WO2007038829A1 (en) 2005-10-04 2006-10-03 Method of drug design

Publications (1)

Publication Number Publication Date
DK1934388T3 true DK1934388T3 (da) 2013-02-25

Family

ID=37905903

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06790302.1T DK1934388T3 (da) 2005-10-04 2006-10-03 Fremgangsmåde til lægemiddeludvikling

Country Status (9)

Country Link
US (2) US8426345B2 (da)
EP (1) EP1934388B1 (da)
JP (1) JP5174672B2 (da)
CN (2) CN102796147A (da)
CA (1) CA2619457C (da)
DK (1) DK1934388T3 (da)
ES (1) ES2400509T3 (da)
PL (1) PL1934388T3 (da)
WO (1) WO2007038829A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102796147A (zh) 2005-10-04 2012-11-28 阿尔卡米亚有限公司 化合物库
JOP20190215A1 (ar) * 2017-03-24 2019-09-19 Ionis Pharmaceuticals Inc مُعدّلات التعبير الوراثي عن pcsk9

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018971A1 (en) 1994-01-11 1995-07-13 Affymax Technologies N.V. Methods for the solid phase synthesis of glycoconjugates
AU2341197A (en) * 1996-03-21 1997-10-10 Intercardia, Inc. Solid phase lipoglycopeptide library, compositions and methods
DE69835679T2 (de) * 1997-08-28 2007-08-23 Biomira, Inc., Edmonton Zufälligverteilt erzeugte kombinatorische peptidbibliotheken
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
CN1314913A (zh) * 1998-06-10 2001-09-26 格里科设计公司 有针对性的组合化合物库及其进行筛选所用的高效测定方法
US7338932B2 (en) * 2000-05-11 2008-03-04 Glycozym Aps Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
AUPS143402A0 (en) 2002-03-28 2002-05-09 Alchemia Pty Ltd Anomeric derivatives of monosaccharides
AU2002950657A0 (en) * 2002-08-08 2002-09-12 Alchemia Limited Derivatives of monosaccharides for drug discovery
AU2002951247A0 (en) * 2002-09-06 2002-09-19 Alchemia Limited Compounds that interact with kinases
AU2002951995A0 (en) * 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
US20080280837A1 (en) * 2004-04-08 2008-11-13 Judy Halliday Biologically Active Compounds with Anti-Angiogenic Properties
CN102796147A (zh) 2005-10-04 2012-11-28 阿尔卡米亚有限公司 化合物库

Also Published As

Publication number Publication date
CN101278079B (zh) 2012-09-19
EP1934388A4 (en) 2010-07-21
CA2619457C (en) 2016-09-06
ES2400509T3 (es) 2013-04-10
US20090163373A1 (en) 2009-06-25
US20130172210A1 (en) 2013-07-04
CN102796147A (zh) 2012-11-28
EP1934388B1 (en) 2012-12-05
CA2619457A1 (en) 2007-04-12
JP5174672B2 (ja) 2013-04-03
CN101278079A (zh) 2008-10-01
WO2007038829A8 (en) 2008-03-27
EP1934388A1 (en) 2008-06-25
US9709571B2 (en) 2017-07-18
US8426345B2 (en) 2013-04-23
JP2009510130A (ja) 2009-03-12
WO2007038829A1 (en) 2007-04-12
PL1934388T3 (pl) 2013-04-30

Similar Documents

Publication Publication Date Title
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DK2041139T3 (da) Farmaceutiske forbindelser
DK1962932T3 (da) Indretning til medikamentdosering
DE602006007875D1 (de) Kapseln
DE602005006185D1 (de) Entwicklungsverfahren
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK1957073T3 (da) Lægemiddel
DK2047098T3 (da) Kalibreringsfremgangsmåde
DK1860941T3 (da) Biphenyl-N-(4-pyridyl)methylsufonamider
DK1880781T3 (da) Fremgangsmåde til kasseløs formning
DK1910325T3 (da) Nye farmaceutisk forbindelser
DE602007013849D1 (de) Mikroreaktor
DE602006012689D1 (de) Überprüfungsverfahren
DK2020845T3 (da) Fremgangsmåde til høstning
DK1943240T3 (da) Kemisk fremgangsmåde
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
DK1955066T3 (da) Membran-assay-fremgangsmåde
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
DE602006018034D1 (de) Enzymherstellungsverfahren
JP2008525507A5 (ja) 置換された4−アルコキシカルボニル−3−アミノチオフェン類の製造方法
DE602006003519D1 (de) Aufzeichnungsverfahren
NO20054652D0 (no) Fremgangsmate for fremstilling
FI20041315A0 (fi) Prosessi
NO20053978D0 (no) Process.
SE0401623D0 (sv) New process